Breaking News, Promotions & Moves

Takeda Appoints Rhonda Pacheco as President of U.S. Business Unit

Pacheco comes to Takeda from Eli Lilly where she oversaw complex portfolios in a range of leadership roles.

Author Image

By: Charlie Sternberg

Associate Editor

Takeda has appointed Rhonda Pacheco, former group vice president of U.S. Cardiometabolic Health at Eli Lilly, as president of Takeda’s U.S. Business Unit and a member of the Takeda Executive Team, effective September 29, 2025. Pacheco will succeed Julie Kim, who was appointed to succeed Christophe Weber as president and Chief Executive Officer (CEO) of Takeda in June 2026. With Pacheco’s appointment, Kim will focus on preparing for the CEO transition, which includes serving as interim head of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters